Trial Profile
Prognostic score for patients with advanced melanoma treated with ipilimumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Dec 2015
Price :
$35
*
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 01 Dec 2015 New trial record
- 18 Nov 2015 Results published in the European Journal of Cancer